Table 1

Characteristics of study participants

Variables*Total (N=2121)Male (N=2041)Female (N=80)
Age (years) (p=0.024)
 18–29251 (11.8)243 (11.9)8 (10.0)
 30–39811 (38.2)769 (37.7)42 (52.5)
 40–49653 (30.8)639 (31.3)14 (17.5)
 50–79406 (19.1)390 (19.1)16 (20.0)
Ethnicity (p=0.023)
 Han885 (41.7)854 (41.8)31 (38.8)
 Jingpo909 (42.9)880 (43.1)29 (36.3)
 Dai249 (11.7)231 (11.3)18 (22.5)
 Others78 (3.7)76 (3.7)2 (2.5)
Marital status (p=0.156)
 Never married378 (17.8)368 (18.0)10 (12.5)
 Current married1495 (70.5)1439 (70.5)56 (70.0)
 Divorced or widowed248 (11.7)234 (11.5)14 (17.5)
Education level (p=0.001)
 Illiteracy or primary1063 (50.1)1038 (50.9)25 (31.3)
 Middle816 (38.5)777 (38.1)39 (48.8)
 High or above242 (11.4)226 (11.1)16 (20.0)
Age at first drug use (years) (p=0.778)
 <251199 (56.5)1155 (56.6)44 (55.0)
 ≥25922 (43.5)886 (43.4)36 (45.0)
Length of MMT (years) (p=0.086)
 <1367 (17.3)360 (17.6)7 (8.8)
 1–51085 (51.2)1043 (51.1)42 (52.5)
 >5669 (31.5)638 (31.3)31 (38.8)
Daily methadone dose (mL) (p=0.444)
 ≤30335 (16.4)327 (16.7)8 (10.1)
 31–60765 (37.5)732 (37.3)33 (41.8)
 61–99528 (25.9)508 (25.9)20 (25.3)
 ≥100411 (20.2)393 (20.1)18 (22.8)
Number of sexual partners in the past year (p=0.357)
 0601 (28.4)581 (28.5)20 (25.0)
 11441 (68.1)1386 (68.0)55 (68.8)
 ≥275 (3.5)70 (3.4)5 (6.3)
HIV infection (p=0.405)
 No1670 (78.7)1610 (78.9)60 (75.0)
 Yes451 (21.3)431 (21.1)20 (25.0)
HCV infection (p=0.698)
 No1335 (62.9)1283 (62.9)52 (65.0)
 Yes786 (37.1)758 (37.1)28 (35.0)
  • *p Value obtained from χ2 tests.